By Linda Satter
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) recently became the first provider in Arkansas of NanoKnife technology, a new form of focal therapy for localized prostate cancer.
Focal therapy is a minimally invasive outpatient procedure that uses different forms of energy to target only the area of the prostate where cancerous cells are located and destroy them while sparing damage to surrounding tissue. It carries a lower risk of side effects — such as erectile dysfunction and urinary incontinence — than radiation and surgery, which are the other treatments for prostate cancer.
The NanoKnife form of focal therapy uses irreversible electroporation (IRE), which consists of short, high-voltage electrical pulses, to isolate the tumor without overtreating the entire prostate gland.
In a First for Arkansas, UAMS Uses NanoKnife Technology to Treat Prostate Cancer